Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

View Larger Image

Past Issues Free Subscriptions

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• Protein Characterization
• Protein Detection
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

Induced Pluripotent Stem Cells - Related Content

• Page 1 of 1 (5 items) 1 

• Insight & Intelligence™

• In Vitro Clinical Trials: Not that Far-Fetched
  November 2, 2012
  Scientists foresee a time when induced pluripotent stem cells could be used to predict patients’ response to a drug.
• Prizes and Quackery Dominate iPS Cell News
  October 22, 2012
  Through ups and downs, the question remains: Do induced pluripotent stem cells have near-term clinical potential?
• California Stem Cell Agency’s Road to Success for Next Five Years Will Have to Run Through the Clinic
  January 24, 2012
  As CIRM considers direction and required financing going forward, it will have to show progress to win support.
• Back to the Future with Somatic Progenitor Cells
  March 30, 2011
  Sanford-Burnham scientists developed a way to expand these cells without risking uncontrolled replication.
• GEN Exclusive: 2009 Laskers Honor Advances in Stem Cell Technology and Cancer Therapy
  September 14, 2009
  Work cited will revolutionize cancer therapy and impact a potential $700 million global stem cell market.

• Page 1 of 1 (5 items) 1